Results 261 to 270 of about 72,471 (294)
Some of the next articles are maybe not open access.
Quinidine-Rifampin Interaction
New England Journal of Medicine, 1981DRUG interactions with quinidine are likely to be clinically important, since quinidine is used in the treatment and prophylaxis of potentially serious arrhythmias, and since there is a relatively narrow range between the therapeutic and toxic concentrations.1 An interaction between quinidine and the anticonvulsant drugs primidone and phenobarbital has
Twum-Barima Y, Carruthers Sg
openaire +3 more sources
Archives of Dermatology, 1977
To the Editor.— I was very interested in the letter by Griffiths and Sodeify ( Arch Dermatol 112:1791, 1976) in which rifampin is mentioned as a valuable drug for the treatment of cutaneous leishmaniasis. I would like to report the case of a 19-year-old woman who had a 4 × 4-cm ulcer of eight months' duration on the right forearm.
openaire +2 more sources
To the Editor.— I was very interested in the letter by Griffiths and Sodeify ( Arch Dermatol 112:1791, 1976) in which rifampin is mentioned as a valuable drug for the treatment of cutaneous leishmaniasis. I would like to report the case of a 19-year-old woman who had a 4 × 4-cm ulcer of eight months' duration on the right forearm.
openaire +2 more sources
Interaction of Rifampin and Nortriptyline
The American Journal of the Medical Sciences, 1996Rifampin is well documented to cause numerous clinically significant drug interactions because of its induction of the hepatic cytochrome P450 system. The metabolism of nortriptyline and other tricyclic antidepressants is induced and inhibited by this enzyme system.
Thomas L. Abell +3 more
openaire +4 more sources
Rifampin in Chlamydial Infections
Clinical Infectious Diseases, 1983On a weight basis, rifampin is the antibiotic most active against Chlamydia trachomatis. Because of concerns about the ease with which resistance to rifampin emerges in vitro, few clinical trials of rifampin for the treatment of human chlamydial infections have been done.
openaire +3 more sources
TO RIFAMPIN OR NOT TO RIFAMPIN?!
Journal of the American College of Cardiology, 2022Faysal Alhasan +2 more
openaire +1 more source

